What strategies can a perimenopausal woman (aged 45‑55) use to reduce her risk of dementia and Alzheimer’s disease?

Dementia Risk Reduction for Perimenopausal Women

A perimenopausal woman should prioritize regular moderate-intensity aerobic exercise (at least 10 MET-hours/week), adopt a Mediterranean diet rich in mono- and polyunsaturated fatty acids, ensure 7-8 hours of sleep nightly, and address hearing impairment if present—these evidence-based interventions offer the strongest protection against future dementia and Alzheimer's disease.

Physical Activity: The Most Robust Intervention

Engage in aerobic exercise and/or resistance training of at least moderate intensity to reduce dementia risk. 1 The Canadian Consensus Conference provides Level 1B evidence (96% consensus) specifically recommending physical activity interventions to reduce risk of dementia, including Alzheimer's disease and vascular dementia.

Recent research targeting perimenopausal women specifically demonstrates a dose-response relationship: approximately 10 MET-hours per week of leisure-time physical activity is required for significant dementia risk reduction 2. Higher levels of perimenopausal household and leisure physical activity show favorable impacts, with three of four studies providing evidence against reverse causation—meaning the activity itself is protective, not simply a marker of better health 2.

Practical implementation:

• Aerobic exercise: brisk walking, swimming, cycling
• Resistance training: weight-bearing exercises 2-3 times weekly
• Mind-body exercises like Tai Chi or Qigong show promise but need more evidence (Level 2B) 1

Nutrition: Mediterranean Diet as Foundation

Adhere to a Mediterranean diet pattern (Level 1B, 91% consensus) 1. This is not a vague recommendation—the specifics matter:

• High consumption of mono- and polyunsaturated fatty acids (Level 1B, 92% consensus) 1
• Low consumption of saturated fatty acids 1
• Increase fruit and vegetable intake (Level 1B, 88% consensus) 1
• Fatty fish intake: Women specifically benefit from nonfried and fatty fish consumption, with evidence showing lower rates of myocardial infarction, cardiovascular death, and Alzheimer's death 3

Regarding omega-3 supplementation: DHA appears more beneficial than EPA for cognitive outcomes, and supplementation works best when started before cognitive decline begins—making perimenopause an ideal window 3. Women show cognitive benefit in randomized controlled trials of EPA and DHA supplementation 3.

Sleep Optimization: A Critical 7-8 Hour Target

Target 7-8 hours of sleep per night (Level 1C, 94% consensus) 1. Avoiding severe sleep deprivation (<5 hours) may improve cognition and decrease dementia risk 1.

Screen for sleep apnea symptoms (Level 1C, 96% consensus) 1:

• Ask about snoring, witnessed apneas, daytime sleepiness
• If suspected, refer for polysomnography
• Treat confirmed sleep apnea with CPAP, which may improve cognition and decrease dementia risk 1

Include assessment of insomnia, daytime sleepiness, napping patterns, and REM sleep behavior disorder in your evaluation 1.

Hearing Assessment and Correction

Screen for hearing impairment (Level 1B, 87% consensus) 1. There is sufficient observational evidence that hearing impairment associates with dementia development.

Specific approach (Level 1A, 93-98% consensus) 1:

• Ask: "Do you have any difficulty hearing in your everyday life?" (not "Do you have hearing loss?")
• If symptoms reported, confirm with audiometry by a licensed audiologist
• Implement audiologic rehabilitation, which may include behavioral counseling and/or hearing aids
• Review medications for ototoxicity
• Refer to otolaryngology for chronic otitis media or failed otoscopy

Cardiovascular Risk Factor Management

Control hypertension aggressively. Among persons with hypertensive blood pressure levels (SBP ≥140 or DBP ≥90 mmHg), use of any antihypertensive medication with efficacy to lower blood pressure reduces dementia risk (HR 0.88) and Alzheimer's disease risk (HR 0.84) 4. No specific drug class proves superior—the key is achieving blood pressure control.

Address glucose metabolism:

• Impaired fasting glucose (5.6-6.9 mmol/L) increases dementia risk by 25% (HR 1.25) 5
• Hyperglycemic levels (≥7.0 mmol/L) increase risk by 45% (HR 1.45) 5
• This dose-response relationship makes glucose control critical during perimenopause

Maintain physical activity for weight management: Interestingly, being overweight in late-life shows a protective effect (HR 0.75) 5, though this should not override cardiovascular health considerations during perimenopause.

Mental Health and Cognitive Engagement

Screen for and treat depression aggressively. Depression increases all-cause dementia risk by 75% (HR 1.75) in postmenopausal women 5. This is a modifiable risk factor that demands attention during the perimenopausal transition when mood disturbances are common.

Promote cognitively stimulating activities 6. Educational attainment, cognitive engagement, and social connection all associate with decreased dementia risk 6.

Critical Caveats About Hormone Therapy

Do not initiate hormone replacement therapy for dementia prevention. The evidence is insufficient and potentially contradictory 7, 8:

• The 2003 U.S. Preventive Services Task Force explicitly recommended against routine HRT for chronic disease prevention 7
• While some observational data suggest benefit when started early in menopause, randomized controlled trials (WHI, HERS) showed no cognitive benefit in older postmenopausal women 7, 8
• The "window of opportunity" hypothesis (benefit if started within 5 years of menopause) remains controversial and unproven for dementia prevention 8
• If HRT is used for menopausal symptom management, use the lowest effective dose for the shortest time 7

Recent research emphasizes that estrogen decline during perimenopause and menopause negatively impacts brain health 9, 10, 11, 12, but translating this into clinical hormone therapy recommendations for dementia prevention lacks sufficient evidence 9.

The Perimenopausal Window of Opportunity

This is the critical intervention period. Women face disproportionate dementia burden, with nearly two-thirds of Alzheimer's patients being women 12. The menopause transition represents a distinct window of vulnerability—and opportunity 12:

• Hormone changes at menopause correlate with observable changes in memory, brain structure, and Alzheimer's pathology 13
• APOE4 carriers face heightened risk, particularly during perimenopause 9, 11
• Early menopause and bilateral oophorectomy increase risk 13, 12
• Frequent vasomotor symptoms associate with increased risk 13, 12

By 2050, over 1.2 billion women worldwide will be in or approaching menopause 12. The interventions outlined above—exercise, diet, sleep, hearing correction, cardiovascular risk management, and depression treatment—are all modifiable factors that can be addressed during perimenopause to alter the trajectory of cognitive aging.

Practical Implementation Algorithm

1. Assess current status:

   • Physical activity level (aim for ≥10 MET-hours/week)
   • Dietary pattern (Mediterranean diet adherence)
   • Sleep duration and quality (target 7-8 hours)
   • Hearing function (screen with direct questioning)
   • Blood pressure and glucose levels
   • Depression screening

2. Prioritize interventions based on gaps:

   • Start aerobic exercise immediately if sedentary
   • Transition to Mediterranean dietary pattern
   • Address sleep disorders (especially sleep apnea)
   • Correct hearing impairment if present
   • Control hypertension and hyperglycemia
   • Treat depression if identified

3. Monitor and adjust:

   • Physical activity should be at least moderate intensity
   • Dietary changes should emphasize unsaturated fats and reduce saturated fats
   • Sleep interventions may require specialist referral
   • Hearing correction requires audiologist involvement
   • Cardiovascular risk factors need ongoing management

The evidence strongly supports that these lifestyle and medical interventions during perimenopause can meaningfully reduce late-life dementia risk—making this a critical period for prevention-focused care.